FDA Inspection 1171545 — NEURELEC

NEURELEC — FEI 3016743107

The FDA completed an inspection of NEURELEC on Jun 2, 2022 in Vallauris. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jun 2, 2022
Fiscal Year
2022
Product Type
Devices
Project Area
Project Evaluation: Devices
Location
Vallauris (France)

Additional Details

Postmarket Audit Inspections

Citations

IDCFRDescription
1471321 CFR 820.198(a)Lack of or inadequate complaint procedures
369621 CFR 820.100(b)Documentation